Pliant Therapeutics (PLRX) Shares Issued (2019 - 2020)
Pliant Therapeutics (PLRX) posted quarterly Shares Issued of $3.0 million for Q4 2020, up 123.84% year-over-year from $1.3 million in Q1 2020, and up 6.6% quarter-over-quarter from $2.8 million in Q3 2020.
Pliant Therapeutics (PLRX) Shares Issued (2019 - 2020) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Shares Issued for 2 consecutive years, with $3.0 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Shares Issued rose 123.84% year-over-year to $3.0 million; the TTM figure through Dec 2020 stood at $3.0 million (up 123.84% YoY), while the FY2020 annual figure was $3.0 million, up 123.84% from the prior year.
- Shares Issued advanced to $3.0 million in Q4 2020 per PLRX's latest filing, from $2.8 million in the prior quarter.
- Across five years, Shares Issued topped out at $3.0 million in Q4 2020 and bottomed at $97942.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.99 Mn |
| Dec 31, 2020 | 2.99 Mn |
| Sep 30, 2020 | 2.81 Mn |
| Sep 30, 2020 | 2.81 Mn |
| Jun 30, 2020 | 2.53 Mn |
| Jun 30, 2020 | 2.53 Mn |
| Dec 31, 2019 | 1.34 Mn |
| Dec 31, 2019 | 1.34 Mn |
| Sep 30, 2019 | 1.30 Mn |
| Sep 30, 2019 | 1.30 Mn |
| Jun 30, 2019 | 97,942.00 |
| Jun 30, 2019 | 97,942.00 |